Press Releases and Events
PRESS RELEASES
Press Release | February 1, 2022
Press Release | January 12, 2022
Crinetics Pharmaceuticals to Present Corporate and Clinical Update at 40th Annual J.P. Morgan Healthcare Conference
READ MORE
Press Release | January 5, 2022
Crinetics Pharmaceuticals Adds Board Member with Global Rare Disease Expertise with Appointment of Rogério Vivaldi Coelho, M.D., M.B.A.
READ MORE
Press Release | November 18, 2021
Crinetics Pharmaceuticals to Present at the 4th Annual Evercore ISI HealthCONx Conference
READ MORE
Press Release | November 8, 2021
Crinetics Pharmaceuticals Presenting New Data from Open Label Extension Trial of Paltusotine in Acromegaly at the Society for Endocrinology BES Congress
READ MORE
Press Release | November 5, 2021
Crinetics Pharmaceuticals Reports Third Quarter 2021 Financial Results and Provides Corporate Update
READ MORE
Press Release | October 25, 2021
Crinetics Pharmaceuticals Announces Closing of Public Offering of Common Stock
READ MORE
Press Release | October 21, 2021
Crinetics Pharmaceuticals Announces Pricing of Public Offering of Common Stock
READ MORE
Press Release | October 20, 2021
Crinetics Pharmaceuticals Announces Proposed Public Offering of Common Stock
READ MORE
Press Release | October 18, 2021
Radionetics Oncology Emerges from Crinetics Pharmaceuticals with a Platform and Deep Pipeline of Nonpeptide Targeted Radiopharmaceutical Drug Candidates for Precision Oncology
READ MORE
WEBCAST
PRESS RELEASETransforming Endocrine Disease Treatment
Be the first to know about the advances we're making in endocrine-rooted care.
Email Signup
You are now leaving Crinetics.com
Please click CONTINUE below to learn more about a new treatment option. This website contains information about a prescription medicine.
